FWL Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.89K Hold
52
﹤0.01% 306
2026
Q1
$8.78K Hold
52
﹤0.01% 260
2025
Q4
$8.78K Hold
52
﹤0.01% 284
2025
Q3
$7.51K Sell
52
-4
-7% -$546 ﹤0.01% 271
2025
Q2
$7.08K Sell
56
-15
-21% -$1.84K ﹤0.01% 249
2025
Q1
$9.08K Sell
71
-10
-12% -$1.36K ﹤0.01% 228
2024
Q4
$10.7K Hold
81
﹤0.01% 237
2024
Q3
$11.8K Hold
81
﹤0.01% 230
2024
Q2
$11.1K Sell
81
-195
-71% -$26K 0.01% 188
2024
Q1
$37.9K Sell
276
-33
-11% -$4.51K 0.02% 110
2023
Q4
$42K Sell
309
-39,195
-99% -$4.78M 0.02% 100
2023
Q3
$4.83M Buy
39,504
+1,996
+5% +$254K 3.24% 13
2023
Q2
$4.76M Buy
37,508
+14,055
+60% +$1.83M 3.25% 13
2023
Q1
$3.03M Buy
23,453
+23,437
+146,481% +$3.07M 2.23% 17
2022
Q4
$2.1K Hold
16
﹤0.01% 170
2022
Q3
$2K Buy
+16
New +$1.99K ﹤0.01% 59
2021
Q2
Sell
-19,534
Closed -$2.94M 50
2021
Q1
$2.94M Buy
19,534
+2,084
+12% +$331K 1.98% 24
2020
Q4
$2.64M Buy
+17,450
New +$2.49M 2.02% 24

Other funds holding IBB

FWL Investment Management's IBB Position: Q2 2026 in Review

FWL Investment Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 52 shares worth $9.89K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

FWL Investment Management first reported a position in IBB in Q4 2020 and has held it in 18 quarters since. The position peaked at $4.83M in Q3 2023. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • FWL Investment Management held 52 shares of iShares Biotechnology ETF worth $9.89K as of Q2 2026.
  • FWL Investment Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of FWL Investment Management's portfolio in Q2 2026, its #306 holding.
  • FWL Investment Management first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 18 quarters since.
  • FWL Investment Management's iShares Biotechnology ETF position peaked at $4.83M in Q3 2023.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on FWL Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.